Atlas Trials

A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease

Clinical trial NCT04492722 · TERMINATED

Trial details

NCT number
NCT04492722
Sponsor
AstraZeneca
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Kidney Disease
Start date
2020-10-01
Primary completion
2022-09-06
Enrollment
613

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.